Zentiva 1st Half Net Profit +19% At CZK987.5 Million Vs CZK831.3M Year Ago
Monday August 4th, 2008 / 11h28
By Sean Carney Of DOW JONES NEWSWIRES PRAGUE -(Dow Jones)- Czech-based generics drug maker Zentiva NV (BAAZEN.PR) Monday reported an 19% annual rise in first-half net profit, as foreign units began to contribute to the group's profits. Zentiva, which was recently the subject of a takeover battle between its two largest shareholders, said net profit in the six months to end-June totaled CZK987.5 million ($64.3 million), compared with CZK831.3 million a year ago. Last month the company reported its revenue totaled CZK4.50 billion in the second quarter, up 31.6% from CZK3.42 billion a year earlier. Immediately following the first-half earnings release, Zentiva then announced that its net profit in the second quarter was up 16% on the year at CZK363.3 million, compared with CZK312.4 million a year ago. The profit figure is below market expectations for net profit of CZK460 million, according to a Dow Jones Newswires poll of six analysts. At 1001 GMT, Zentiva was trading up 0.6%, on the day at CZK1072 and down 9.7% year-on-year. Company Web site: http://www.zentiva.cz -By Sean Carney; Dow Jones Newswires; +420 221 085 272; sean.carney@dowjones.com Click here to go to Dow Jones NewsPlus, a web front page of today's most important business and market news, analysis and commentary: http://www.djnewsplus.com/al?rnd=gnR9y3EUeVwGMWuM34KHkA%3D%3D. You can use this link on the day this article is published and the following day.
Sanofi-Aventis est le 1er groupe pharmaceutique europ éen. Le CA par famille de produits se répartit comme suit :
- produits pharmaceutiques (89,6%)...
